Acquisition includes USA Drug, Super D Drug, May’s Drug, Med-X and Drug Warehouse Stores Transaction expands Walgreens presence in region including smaller communities
Public-private initiative can help reduce stigma through testing at select community pharmacies and retail clinics, provide greater access to resources and care
- Together Walgreens and Alliance Boots are uniquely positioned to anticipate the rapidly changing global health and wellbeing marketplace to the benefit of customers, employees and business partners - - Walgreens to initially invest $6.7 billion in cash and stock to acquire a 45% equity interest in
Results include 1 cent per diluted share due to costs related to strategic transaction with Alliance Boots announced today Operating cash flow reaches a record $1.9 billion in third quarter and a record $3.7 billion through first nine months of fiscal year Company increases quarterly dividend 22.2
– New Walgreens study shows that two enhanced pharmacist counseling sessions can significantly improve patient adherence to medications that reduce the risk of heart disease –
- Industry-leading program provides discounts on more than 8,000 medications, including more than 700 value-priced generics - - Program can help increase access, medication adherence and savings for uninsured and underinsured members -
Immunizations available daily with no appointment necessary as health officials stress importance of adult immunizations to help prevent spreading disease to infants, children
Everyday availability with no appointment necessary for a variety of vaccines to help protect against shingles, flu, whooping cough, meningitis and other diseases